#United States #New York #Type 1 Diabetes #Breakthrough T1D #Land O'Frost

Breakthrough T1D and Land O'Frost: A Partnership for Progress

Breakthrough T1D, previously known as JDRF, has announced a significant collaboration with Land O'Frost, a family-owned brand renowned for its deli meats and specialty protein products. This partnership is poised to play a vital role in driving research and support for Type 1 Diabetes (T1D), a condition affecting millions worldwide.

Founded in 1941, Land O'Frost is a staple in American households, recognized for its popular packaged meats. The company has consistently aligned itself with charitable initiatives, particularly in the realm of diabetes research, thanks to the personal connection of its CEO, David Van Eekeren, whose child lives with T1D. This partnership signifies a unified effort toward a common goal—the pursuit of innovative treatments and a potential cure for T1D.

Commitment to Type 1 Diabetes Research

Land O'Frost’s dedication to Breakthrough T1D has been longstanding, stretching back to 2008. Over the years, the company has contributed over $2 million towards T1D research, encompassing sponsorships, community support, volunteer efforts, and extensive fundraising initiatives. This financial and moral support has enabled Breakthrough T1D to progress significantly in its mission to improve the lives of those living with T1D.

As highlighted by Brett Collins, Vice President of Corporate and Institutional Giving at Breakthrough T1D, partnerships like the one with Land O'Frost are crucial in impacting the work necessary to foster breakthroughs in treatment and care for T1D. The alignment of Land O'Frost with the organization's vision enhances the capacity for both entities to achieve shared objectives toward improving outcomes for T1D patients.

David Van Eekeren, the company’s president, expressed pride in furthering the partnership, emphasizing that Land O'Frost’s values resonate deeply with the mission of Breakthrough T1D. This statement reflects a collective commitment to drive progress, asserting that the potential for breakthroughs in T1D research is on the horizon.

Understanding Type 1 Diabetes (T1D)

Type 1 Diabetes is an autoimmune disorder that results in the pancreas producing minimal or no insulin. This condition requires individuals to rely on external insulin sources and poses risks of serious health complications, including fluctuations in blood sugar levels that can lead to long-term damage to vital organs. While most people associate T1D with childhood diagnoses, a significant number of adult cases exist, stressing the need for continuous research and public awareness.

Currently, there is no cure for T1D. However, each partnership and investment like those from Land O'Frost aids in unlocking new possibilities and advancements in research, ultimately aiming to alleviate the daily challenges faced by individuals living with the condition.

A Future of Hope

As Breakthrough T1D and Land O'Frost embark on this journey together, the hope for a brighter future for T1D patients becomes ever more tangible. The commitment from a brand that cares profoundly about its community not only fuels research but also inspires awareness and education about T1D. As the collaboration unfolds, we can anticipate significant strides toward improved treatment methodologies, the pursuit of a cure, and, most importantly, enhancing the quality of life for those grappling with Type 1 Diabetes.

In conclusion, the collaboration between Breakthrough T1D and Land O'Frost exemplifies how corporate partnerships can lead to substantial advancements in health-focused research. Through the continued support and engagement of passionate businesses, the fight against T1D becomes a collective mission that holds the promise of real change.